152
Views
4
CrossRef citations to date
0
Altmetric
Review

Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor

, ORCID Icon, &
Pages 169-180 | Published online: 18 Aug 2021